BioInsights - Vol 4 Issue 4

CELL & GENE THERAPY INSIGHTS

April 2018 Issue

Vol 4 Issue 4

Featuring

Issue Spotlight: Latest Advances in CAR-T Cell Manufacture & Clinical Developments
Other articles
Webinar

SPOTLIGHT

Latest Advances in CAR-T Cell Manufacture & Clinical Developments
Bruce Levine
Guest Editor:
Bruce Levine, Professor at University of Pennsylvania
Co-sponsor Co-sponsor Co-sponsor

Expert Insight

Advances in Targeting CAR-T Therapy for Immune-Mediated Diseases

Advances in Targeting CAR-T Therapy for Immune-Mediated Diseases

Jinmin Lee, Aimee S Payne
14 May 2018
Read
Overcoming Challenges for Engineered Autologous T Cell Therapies

Overcoming Challenges for Engineered Autologous T Cell Therapies

M Better, V Chiruvolu, M Sabatino
14 May 2018
Read
Ethical Considerations in the Translation of CAR-T Cell Therapies

Ethical Considerations in the Translation of CAR-T Cell Therapies

K Imbach, A Patel, A Levine
14 May 2018
Read
Strategies to Control CAR-T Cell Therapy: Perspective on Next-Generation CARs

Strategies to Control CAR-T Cell Therapy: Perspective on Next-Generation CARs

Eduardo Laborda, Travis S Young
14 May 2018
Read

Innovator Insight

Utilization of Recombinant Albumins in the Expansion of Human T Lymphocytes

Utilization of Recombinant Albumins in the Expansion of Human T Lymphocytes

Atherly Pennybaker, Randall Alfano
29 May 2018
Read
The Importance of Collection, Processing & Biopreservation Best Practices in Determining CAR-T Starting Material Quality

The Importance of Collection, Processing & Biopreservation Best Practices in Determining CAR-T Starting Material Quality

Lou Juliano, George Eastwood
29 May 2018
Read

Interview

Challenges in Developing GMP-Compliant Manufacturing Facilities for CAR-T Cells

Challenges in Developing GMP-Compliant Manufacturing Facilities for CAR-T Cells

Lothar Germeroth
6 June 2018
Read
Innovative Technologies for CAR-T Manufacturing: the Key to Commercialization

Innovative Technologies for CAR-T Manufacturing: the Key to Commercialization

Stanley Kowalski, Daniella Kranjac
4 June 2018
Read
Unlocking the Potential of CAR-T Therapies for Solid Tumors

Unlocking the Potential of CAR-T Therapies for Solid Tumors

Tamara Laskowski
4 June 2018
Read
Driving CAR-T Manufacture Optimization through Technology Innovation

Driving CAR-T Manufacture Optimization through Technology Innovation

Philip H Coelho
4 June 2018
Read
Addressing the Challenges of Commercial-Scale Manufacture of Viral Vectors for CAR-T Therapies

Addressing the Challenges of Commercial-Scale Manufacture of Viral Vectors for CAR-T Therapies

Calley Hirsch, Xavier de Mollerat du Jeu
29 May 2018
Read
Pricing Models & Strategies to Make CAR-T Therapy Affordable

Pricing Models & Strategies to Make CAR-T Therapy Affordable

Dan Ollendorf
14 May 2018
Read
Advances in using CAR-T cell therapy to treat HIV

Advances in using CAR-T cell therapy to treat HIV

Scott Kitchen
14 May 2018
Read
Commercial Business Models for Immunotherapies

Commercial Business Models for Immunotherapies

Helen Tayton-Martin
14 May 2018
Read
Utlization of CAR-T therapy for ovarian cancer

Utlization of CAR-T therapy for ovarian cancer

Janos Tanyi
14 May 2018
Read

Journal articles

Interview

Fixing the weak links in the cell therapy manufacturing chain: processes, people and partnerships

Fixing the weak links in the cell therapy manufacturing chain: processes, people and partnerships

Phil Vanek
30 April 2018
Read

Podcast

Fixing the weak links in the cell therapy manufacturing chain: processes, people and partnerships

Fixing the weak links in the cell therapy manufacturing chain: processes, people and partnerships

Phil Vanek
8 May 2018
Listen

Commercial Insights

Cell & Gene Therapy Commercial Insight – April 2018

Cell & Gene Therapy Commercial Insight – April 2018

Mark Curtis, Richard Philipson
16 May 2018
Read

Webinars